ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
94,218.61
-0.50%
S&P 500
5,974.07
0.73%
Dow Jones
42,906.95
0.00%
US Dollar vs Yen
157.131
-0.03%
Brent Oil
72.845
0.20%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Tenax Therapeutics Inc (TENX)

  7. Tenax Therapeutics Inc (TENX) ニュース

TENX

Tenax Therapeutics (TENX)

Tenax Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TENX
日付受信時刻ニュースソース見出しコード企業名
2024/12/1310 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/1310 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/1310 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/1310 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/1309 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/1309 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/1309 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/0706 : 54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
2024/12/0603 : 47Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
2024/12/0507 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENXTenax Therapeutics Inc
2024/11/2706 : 30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TENXTenax Therapeutics Inc
2024/11/1509 : 14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
2024/11/1502 : 39Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TENXTenax Therapeutics Inc
2024/11/1502 : 21Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TENXTenax Therapeutics Inc
2024/11/1407 : 35Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TENXTenax Therapeutics Inc
2024/11/1406 : 04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENXTenax Therapeutics Inc
2024/11/1322 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENXTenax Therapeutics Inc
2024/11/1223 : 32Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
2024/11/0105 : 05GlobeNewswire Inc.Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation ConferenceNASDAQ:TENXTenax Therapeutics Inc
2024/10/3105 : 32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENXTenax Therapeutics Inc
2024/09/2721 : 14Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TENXTenax Therapeutics Inc
2024/09/1313 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TENXTenax Therapeutics Inc
2024/09/1305 : 15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TENXTenax Therapeutics Inc
2024/09/1106 : 19Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
2024/08/3105 : 20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TENXTenax Therapeutics Inc
2024/08/3105 : 19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TENXTenax Therapeutics Inc
2024/08/2405 : 31Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:TENXTenax Therapeutics Inc
2024/08/2007 : 48Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
2024/08/2005 : 15Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
2024/08/1605 : 19Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TENX

最近閲覧した銘柄

PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
NYSE
NKE
Nike
CCOM
US100
US Tech 100
NASDAQ
TSLA
Tesla
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
NASDAQ
AMZN
Amazon.com
CCOM
US500
US 500
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有